Bitcoin recently dropped to around $67,770, its lowest in 12 weeks, triggering a rare buy signal as it returned to its 200-week moving average and its daily RSI fell to 25, indicating oversold conditions. Analyst Vetle Lunde sees this as a buying opportunity rather than a reason to panic, noting reduced speculative positions with significant ETF outflows and low leveraged exposure. However, some caution remains as prices can stay pressured amid uncertain macroeconomic conditions. Institutional factors, like Grayscale's strong Bitcoin holdings, also influence market outlooks.
Bitcoin trades at Rp1.256.996.304 on Pluang as of Nov 14, 2026 03:22 WIB, down 3.38% in one day. The platform shows a strong buy interest with 67% of orders favoring buying. Typical holding time on Pluang is 113 days, indicating medium-term investor confidence despite recent price drops.
Research by Sentora shows Bitcoin dropped on 92% and Ether on 95% of the worst U.S. stock market days since 2022, indicating both cryptos often fall alongside equities during major selloffs. Ether underperformed Bitcoin on 79% of these days, with med...
Bitcoin fell 4.1% to $68,760 on November 13, 2026, marking its lowest level since August and a rare Friday the 13th decline. The sell-off wiped out $1.31 billion in leveraged positions, mostly long bets, amid fears driven by US inflation concerns and...
Bitcoin's price dropped below $70,000 following over $455 million in liquidations, mostly from long positions. The crypto market is experiencing extreme fear with total liquidations exceeding $856 million, including significant losses in Ethereum and...
Michael Saylor, founder of Strategy, warns that AI is making cyberattacks faster and more effective, especially targeting complex financial software like exchanges and wallets. He argues Bitcoin's simpler base layer, using SHA-256 hashing and proof-o...
Bitway (BTW) experienced the largest loss among 90 major cryptocurrencies, dropping 14.06% to $0.870, ranking 65th by market cap. Overall, more cryptocurrencies declined (52) than advanced (38) in the latest snapshot. Injective (INJ) led gains with a...
